Department news | January 31, 2024
When it opens its doors this spring, the new Garvey Institute Center for Neuromodulation will dramatically improve our ability to improve access to treatments such as electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), and other novel therapeutics in one convenient location in the new Center for Behavioral Health and Learning at UWMC-Northwest. Neuromodulation treatments can […]
Department news | January 31, 2024
Over 75 researchers, clinicians, educators and supporters attended the third annual meeting of the Garvey Institute for Brain Health Solutions held today at South Lake Union. Mike and Lynn Garvey who established the Institute with a $ 50 million foundational gift and their daughter Denise Tabbutt and grandson Owen Tabbutt were in the audience as […]
UW Medicine newsroom | December 1, 2023
Harborview Medical Center is one of the first West Coast hospitals to administer the drug, lecanemab. Tom Grabowski, MD, holder of the Tim B. Engle Endowed Professorship for Brain Health Innovations funded by the Garvey Institute, is quoted.
Department news | November 30, 2023
Garvey Institute funds 12 projects to extend the impact of mental health professionals in Washington.
The Washington Post | November 5, 2023
A vaccine could prove especially helpful for users of drugs such as cocaine who fear it might be tainted with fentanyl, says Marco Pravetoni, PhD.
The Spokesman-Review | October 10, 2023
Tom Grabowski, MD, holder of the Tim B. Engle Endowed Professorship for Brain Health Innovations funded by the Garvey Institute, provided insights into Alzheimer’s research.
Department news | September 28, 2023
We are pleased to announce the first round of funding of our new Trainee Research Awards! These awards are part of our new Clinician Scientist Training Program (CSTP) that supports the development of clinician scientists in our department and provides funding and faculty support for trainees to participate in mentored research.
New Atlas | August 29, 2023
Researchers are expected to begin human clinical trials to test vaccines to prevent heroin and fentanyl overdoses. The vaccines start with the work of Marco Pravetoni, PhD.
KING 5 | August 4, 2023
Garvey Institute-funded researcher Tim Althoff, PhD, and David Atkins, PhD, have been developing AI programs as a form of behavioral health therapy.
Department news | July 5, 2023
The Garvey Institute for Brain Health Solutions (GIBHS) has launched a new round of Innovation Grant funding focused on projects that develop and test innovative partnerships that extend the impact of mental health professionals in Washington State.